2023 KTM SV Sponsorship Packet

More documents

Recommendations

Info

SURVIVOR SPOTLIGHT Blake Hastings Blake Hastings went into the clinic for an MRI of his foot for what he was sure was a broken bone. But sitting in the exam room alone, the then-37-year-old received the news he never expected to get: he had cancer. It was likely Ewing sarcoma, a type of cancer of the bones or the soft tissue around them. A family friend at his diagnosing clinic made a call that would change Blake’s life. Six hours later, Blake and Carey met with M Health Fairview orthopedic surgeon Denis Clohisy, M.D., a member of the renowned Masonic Cancer Center, University of Minnesota. “When it comes to Ewing sarcoma, it’s really premature to advise amputation until we’ve seen the effect of the chemotherapy,” Clohisy says. “In most cases, it shrinks the tumor and therefore results in a surgical treatment that’s less debilitating than one might have thought at the beginning.” Blake spent a grueling nine months in treatment – but at home. For weeks at a time, he’d barely leave his bed. He spent about 15 days in the hospital total. In the end, Blake was able to keep his leg, losing only part of his foot. About six weeks after his treatments had ended, he felt like he was back to “full steam.” And now, one month short of five years later, the Hastings couldn’t be happier about Blake’s recovery. “The U of M team really managed the care of the person and the health of the person,” Blake says. “I think the medical care is as important as providing that hope for someone, a family, that there is an end zone.” Today the Hastings family is back to life as usual – working, getting the kids to their activities, and going on vacations together. Blake likes to spend his time golfing, skiing, hunting, fishing, and playing basketball – and bragging that he can still beat his kids at any of these activities with only nine toes.
OUR BENEFICIARIES Proceeds from the Killebrew-Thompson Memorial advance cancer research and care at St. Luke’s Cancer Institute and Masonic Cancer Center, University of Minnesota. KTM has donated $21.4 million to these institutions, which has gone directly to cancer research. Our beneficiaries leverage these funds four- to five-fold through matching grants and other funds, increasing the impact of our donation by up to $6 million annually. St. Luke’s Cancer Institute (SLCI) brings cuttingedge clinical trials to Idaho and the Northwest. SLCI provides access to experimental treatments usually only available at hospitals in larger metropolitan areas. Funds contributed by KTM cover research costs incurred by both enrolled patients and SLCI itself, making accessible new treatment pathways. The Masonic Cancer Center (MCC) is advancing cancer care beyond the chemotherapy and radiation treatments of the past. MCC is preeminent in the research of cell therapies to treat leukemia and solid tumor cancers. Support from KTM seeds high impact studies that contribute to the worldwide research community and that improve quality of life for patients and survivors. To learn more about the work of our beneficiaries, visit www.ktmgolf.com/cause
Page 1: 47TH ANNUAL KILLEBREW-THOMPSON •
Page 4 and 5: BOARD OF DIRECTORS Doug Oppenheimer
Page 6 and 7: OUR HISTORY From the baseball diamo
Page 10 and 11: GOLF TOURNAMENT FORMAT Format for P
Page 12 and 13: 2022 TOURNAMENT SPONSORS Diamond Sp
Page 14 and 15: CORPORATE SPONSORSHIPS Sponsorship
Page 16 and 17: PROMOTIONAL SPONSORSHIPS Highlight
Page 18 and 19: PARTICIPANT ACTIVITIES On Thursday
Page 20 and 21: SOCIAL FUNCTIONS Each day of the ev
Page 22: 2023 SCHEDULE OF EVENTS Wednesday,
Page 25 and 26: RESORT AMENITIES Spa at Sun Valley
Page 28: P.O. Box 232 | Sun Valley, ID 83353

2023 KTM SV Sponsorship Packet

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?